Clik here to view.
Cure Research at IAS 2013
Cure research has been a mainstay of recent HIV/AIDS conferences, and the International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention this month in Kuala Lumpur was no...
View ArticleClik here to view.
News from ICAAC 2013
The Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2013), held September 10–13 in Denver, brought together nearly 9,000 participants to discuss the latest research in the...
View ArticleClik here to view.
Ciclopirox and Deferiprone: Promise in the Lab, but No Cure Yet
Two drugs approved for other uses inhibited HIV replication and triggered death of HIV-infected cells in laboratory tests, researchers reported this week. These findings suggest a potential new...
View ArticleClik here to view.
HIV Cure Research Update
Matt Sharp, Louis Breton, and Mike McCune (photo: Liz Highleyman) Experts discussed the latest HIV cure news at a “town hall” forum in San Francisco on October 1 sponsored by the University of...
View ArticleClik here to view.
News from IDWeek 2013
Several thousand researchers, clinicians, public health officials, and others converged in San Francisco last week for IDWeek 2013, a combined conference of the Infectious Diseases Society of America,...
View ArticleClik here to view.
Transgender Women and the HIV Care Cascade
HIV-positive transgender women in San Francisco appear to be getting lost in the “cascade of care” and not getting the maximum benefits from HIV treatment, but a multi-pronged approach could help turn...
View ArticleClik here to view.
Microbicides and Biomedical Prevention at EACS 2013
The first day of the European AIDS Conference last week in Brussels featured a satellite symposium on HIV microbicides and pre-exposure prophylaxis (PrEP), sponsored by the CHAARM (Combined Highly...
View ArticleClik here to view.
European AIDS Conference Highlights Epidemic in Europe, New Guidelines
The European AIDS Conference, the biennial meeting of the European AIDS Clinical Society (EACS), took place last week in Brussels, the site of the organization’s first meeting 25 years ago. The first...
View ArticleClik here to view.
New HIV Prevention Technologies on the Horizon
Vaginal ring containing tenofovir and levonorgestrel (image: AAPS) A vaginal ring that delivers both tenofovir for HIV prevention and levonorgestrel for contraception, a gel containing the experimental...
View ArticleClik here to view.
New Hepatitis C Drugs Highly Effective but Access Could be a Challenge
Effective new treatments for hepatitis C, including for difficult-to-treat groups such as people with liver cirrhosis and HIV/HCV coinfection, were the focus of the Liver Meeting, the 64th annual...
View ArticleClik here to view.
“Raw Sex”—Are the Rules Changing?
A standing-room-only crowd packed the house at Magnet on December 3 for a lively Real Talk discussion about condomless sex and HIV prevention. mr. Pam (photo: Megan Canon) Moderated by Naked Sword...
View ArticleClik here to view.
Two New Treatments for Hepatitis C
Photo: Gilead Sciences The U.S. Food and Drug Administration recently approved two next-generation hepatitis C drugs that promise to shorten treatment, lessen side effects, and increase cure rates,...
View ArticleNew Hepatitis C Treatment Guidelines Released
The American Association for the Study of Liver Diseases (AASLD), Infectious Diseases Society of America (IDSA), and International Antiviral Society-USA (IAS-USA) this week announced the first new...
View ArticleNew Treatments for Hepatitis C
Hepatitis C was a major theme at the 21st Conference on Retroviruses and Opportunistic Infections this week in Boston. While development of new HIV drugs has slowed in recent years, hepatitis … Read...
View ArticleLong-Acting HIV Drugs for Maintenance and PrEP
Long-acting injectable drug formulations that can last for a month or more may one day offer a more convenient option for HIV maintenance therapy and a way to ensure better … Read More →
View ArticleHIV Cure Research at CROI 2014
The search for a cure has been a major theme at recent HIV meetings, and the 21st Conference on Retroviruses and Opportunistic Infections last week in Boston was no exception. While a … Read More →
View ArticleCan Treatment as Prevention Work for Hepatitis C?
Treating hepatitis C with effective new direct-acting antivirals (DAAs) could dramatically reduce hepatitis C virus transmission, according to several presentations at the European Association for the...
View ArticleInterferon-Free Hepatitis C Treatment Highlighted at EASL Meeting
The interferon-free era of hepatitis C treatment has arrived, as demonstrated by late-stage clinical trial findings presented last week in London at the European Association for the Study of the … Read...
View ArticleNew CDC Guidelines: People at Risk Should Consider PrEP
Health care providers should advise people at “substantial risk” about post-exposure prophylaxis, or PrEP, to prevent HIV infection, according to new guidelines issued today by the Centers for Disease...
View ArticleReal Talk: Undetectable—The New Negative?
More than 100 participants packed an auditorium on May 20 for San Francisco AIDS Foundation’s latest Real Talk forum on HIV prevention strategies, including pre-exposure prophylaxis (PrEP) and...
View Article
